Special care changes needed as costs push patients away
About 1.9 million Australians are delaying or skipping critical medical care due to exorbitant fees for specialist doctors, a report by public policy think tank the Grattan Institute has found.
Some private specialist doctors charge patients two to three times more than the rate Medicare sets for those services, the report found.
It said patients of one specialist forked out an average of $300 per year in 2023 - up 73 per cent since 2010.
Average out-of-pocket costs for extreme-fee-charging specialists in 2023 reached $671 for psychiatry services and more than $350 for endocrinology, cardiology, paediatrics, immunology and neurology services.
The high costs leave critical health care out of reach for millions, causing patients in poorer pockets of Australia to wait months or years for urgent appointments, and leading to missed diagnoses, avoidable pain and added pressure on hospitals.
About four in 10 Australians visited a specialist in 2023/24.
About two-thirds across all specialties are private appointments, with patients receiving a Medicare rebate and paying a gap fee.
Grattan's Health Program director Peter Breadon said the system was broken from start to end.
"Everywhere, from how the system is planned and how training is funded through to how we target public investment and integrate the system between primary care and specialist care, it all really needs a lot of change," he told AAP.
Grattan's recommendations include scrapping Medicare subsidies to specialists who charge excessive fees and publicly naming them.
"Hopefully it would discourage those specialists who are charging really unreasonable fees, but this is a problem that needs many solutions," Mr Breadon said.
The report also recommends governments provide one million extra specialist appointment services every year in areas that receive the least care, a system in which GPs can get written advice from other specialists, modernise public specialist clinics, and allocate $160 million to expand specialist training for undersupplied specialties and rural training.
Australian Medical Association President Danielle McMullen said public hospital underinvestment and lagging Medicare rebates made it harder for patients.
"The risks of delaying medical care are that the health problem gets worse," she said, adding it also puts pressure on GPs and hospitals in public and private clinics.
The doctors' association supports most of Grattan's recommendations, but said removing Medicare funding from specialists who charged excessive fees was not practical.
As governments negotiate the National Health Reform agreement, Dr McMullen urged leaders to sort out longer-term funding for public hospitals and develop a health workforce data tracker to show where investment was needed.
Federal Health Minister Mark Butler said private health insurers and specialists needed to do more to protect patients from exorbitant bills.
He said the Albanese government would upgrade the Medical Costs Finder, which helps patients find the best value for specialist medical advice, and was committed to working with stakeholders to improve cost transparency.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
PHAM Launches Ontario's First-Ever Endo Road Show
Media Invited to Witness a Groundbreaking Women's Health Event That Could Change Lives—and the System OAKVILLE, ON, Aug. 7, 2025 /CNW/ - In collaboration with Dr. Kristy Prouse MD, FRCSC (OB/GYN), one of Canada's most respected leaders in hormonal health, and Endo Diagnosis, the team behind the revolutionary non-invasive Tier-One Diagnostic Test, PHAM is proud to present the first-ever Endo Road Show—a 3-day mobile clinic tour offering Ontario women access to life-changing endometriosis screening and support. From Silent Suffering to Systemic Change 1 in 10 women live with endometriosis, a chronic, immune-mediated neuromuscular disease—not just a "bad period." Yet it still takes most women 7 to 10 years to receive a proper diagnosis. That delay can result in irreversible health consequences. Margaret Wallis-Duffy R.M.T., founder of Preventative Health Awareness Movement (PHAM) recognized by Health Canada, experienced this reality firsthand. For over a decade, she was dismissed, gaslit, and misdiagnosed as a hypersensitive teen seeking attention or painkillers—when in fact, she was battling a debilitating condition. That misdiagnosis led to four bowel obstructions, a lung collapse, fertility issues, and a challenging early menopause . "No woman should have to wait until her body is broken to be believed," says Wallis-Duffy. "If early, non-invasive screening had been available to me, my journey would have looked completely different. This road show is about changing the trajectory for other women—so they can live vibrant, pain-free lives." Today, the current diagnostic standard—laparoscopic surgery—is invasive and expensive, both for women and the healthcare system. This innovative test, offered through Endo Diagnosis, changes everything. In under an hour, it diagnoses endometriosis with 99% accuracy without surgery, offering new hope and earlier intervention. Road Show Dates & Locations August 11 – GraceMed * Functional Medicine & Hormonal Health*, 130 Trafalgar Rd, Oakville August 12 – Drip Bar Barrie, 470 Big Bay Point Rd, Barrie August 13 – Exeter Massage & Integrative Care, 293 Main St South, Exeter Appointments can be booked at: 🎥 ** Media Invitation ** Members of the media are invited to attend any of the three stops to witness firsthand the impact of this empowering initiative. Interview opportunities are available with: Margaret Wallis-Duffy RMT – PHAM Founder & Women's Health Advocate Dr. Kristy Prouse MD, FRCSC (OB/GYN) – Medical Director, GraceMed Functional Medicine & Hormonal Health Endo Diagnosis Team – Distributors behind this Tier-One Test Patients – Sharing raw, real, and hopeful stories Healthcare Providers – Advocating for change on the front lines This is more than a media opportunity—it's a chance to be part of a historic moment in Canadian women's health. Together, we're driving awareness, delivering answers, and transforming her health legacy—one stop at a time. SOURCE PHAM View original content to download multimedia: Sign in to access your portfolio


Medscape
17 minutes ago
- Medscape
Metformin May Shield Against Dementia in Overweight/Obesity
TOPLINE: During a 10-year follow-up, metformin use was associated with significantly lower risks for both dementia and all-cause mortality in patients with overweight or obesity. METHODOLOGY: Metformin, the most widely prescribed glucose-lowering treatment, is linked to a reduced risk for dementia in patients with diabetes; however, its effect on the incidence of dementia among individuals with obesity has not been established with real-world data. Researchers analyzed data from adults with varying degrees of overweight and obesity from a popular global health research network to investigate the link between metformin and the long-term incidence of dementia and all-cause mortality. Adults prescribed metformin at least twice, with a minimum of 6 months between prescriptions, were compared with propensity score-matched control individuals who did not receive the medication; the follow-up period was 10 years. In both the metformin and control groups, the number of participants was 132,920 for BMI 25-29.9; 142,723 for BMI 30-34.9; 94,402 for BMI 35-39.9; and 82,732 for BMI ≥ 40. The primary outcomes measured were dementia and all-cause mortality. TAKEAWAY: After 10 years of follow-up, metformin users had a significantly lower risk for dementia across BMI categories than control individuals (hazard ratio [HR] for BMI 25-29.9, 0.875 [95% CI, 0.848-0.904]; HR for BMI 30-34.9, 0.917 [95% CI, 0.885-0.951]; HR for BMI 35-39.9, 0.878 [95% CI, 0.834-0.924]; and HR for BMI ≥ 40, 0.891 [95% CI, 0.834-0.953]). All-cause mortality was also reduced in metformin users, with HRs ranging from 0.717 to 0.743 across all BMI categories. Age-stratified analysis showed that among patients younger than 65 years, metformin may significantly reduce the risk for dementia for those with BMIs of 30-39.9. IN PRACTICE: 'Regarding the relationship between metformin, dementia, and all-cause mortality, our findings suggest that metformin not only has a protective effect against dementia but also significantly reduces all-cause mortality. Since dementia is a contributing factor to all-cause mortality, this may partially explain metformin's effect,' the authors wrote. SOURCE: This study was led by Yu-Liang Lin, MD, Taipei Medical University, Taipei, Taiwan. It was published online on August 6, 2025, in Diabetes, Obesity and Metabolism. LIMITATIONS: The use of standard diagnostic codes for dementia diagnosis may have contributed to potential misclassification in real-world settings. Due to confidentiality agreements, researchers could not access raw and individualized data, and treatment escalation sequences were unknown. The effects of changes in medication regimens after the second metformin prescription could not be determined. DISCLOSURES: This study did not report any source of funding. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.


Medscape
17 minutes ago
- Medscape
LGBTQ+ Healthcare Professionals Face Hidden Burdens
Pride Month is coming to an end, and headlines about the LGBTQ+ community, as well as rainbow flags on balconies, are gradually disappearing. However, some realities remain a part of daily life, including access to healthcare. LGBTQ+ individuals are often portrayed as existing outside the mainstream rather than as an integral part of society. Many healthcare professionals continue to face unique challenges related to their sexual orientation or gender identity while caring for patients. Irene Aterido, a sociologist and sexologist, serves as coordinator of the Comprehensive Health Group at the State Federation of Lesbians, Gays, Trans, Bisexuals, Intersex, and more (FELGTBI+) in Spain. Speaking with El Médico Interactivo , a Medscape Network platform, Aterido explained that LGBTQ+ healthcare professionals experience a wide range of life circumstances and working conditions. Many individuals continue to encounter challenges in their teams. According to Aterido, LGBTQ+ healthcare professionals are often expected to function as informal educators, helping colleagues understand gender diversity in patient care. These professionals are frequently placed in the spotlight as spokespersons, even when they have not asked for that role. 'Being LGBTQ+ does not mean someone wants to be an activist or is obligated to be one,' Aterido said. LGBTQ+ Professionals 'Just being present can sometimes drive change. However, it is unacceptable that healthcare teams often expect LGBTQ+ professionals to lead training or raise awareness about sexual and gender diversity simply because of who they are. This should not happen,' Aterido continued. 'Equal and accessible care is a right for all patients, and LGBTQ+ healthcare professionals should not be expected to care exclusively for this community, yet this still occurs.' To address this, the Spanish Society of General and Family Physicians (SEMG) and FELGTBI+ recently signed a collaborative agreement aimed at improving primary care for LGBTQ+ individuals. As part of this agreement, FELGTBI+ provides SEMG with technical, educational, and communication materials. These will cover topics such as sexual health, HIV and STI prevention, healthcare rights, and care specific to LGBTQ+ patients. The materials are designed using a community-based, intersectional, and human rights-centred approach. Challenges in the Workplace Alberto Cotillas Rodero, president of the Sociedad Madrileña de Medicina Familiar y Comunitaria (SoMaMFyC) and coordinator of its LGBTQ+ Health Working Group, also spoke to El Médico Interactivo about the challenges many LGBTQ+ clinicians face in the workplace. 'Workplace difficulties can arise regardless of identity or sexual orientation, depending on the environment,' Cotillas Rodero said. Cotillas Rodero explained that medical specialties vary in their openness to diversity. 'Some specialties are more traditionally conservative than others, which can affect how LGBTQ+ professionals are treated.' In family medicine, SoMaMFyC's LGBTQ+ Health Group focuses on improving training related to LGBTQ+ health needs. 'This not only benefits patients but also raises awareness among non-LGBTQ+ clinicians,' Cotillas Rodero said. Aterido added that engagement with diversity training varies widely across specialties. 'Many specialties have not addressed these issues at all — not even at a surface level.' Healthcare and Research According to Aterido, social stigma continues to affect both LGBTQ+ clinicians and patients. 'There are still mental barriers shaped by societal norms. A heteronormative society might accept the idea of a gay nurse, but few people consider that a psychiatrist could be a lesbian or a urologist could be intersex. There are still psychological barriers and stereotypes about the profession.' This stigma affects patient care, particularly in specialties with limited awareness of LGBTQ+ needs. Aterido cited examples such as gynaecologists asking lesbian patients about penetrative sex or assumptions made about breast reconstruction after breast cancer. 'Advances often follow a heteronormative model and may not reflect what breasts mean for LGBTQ+ women,' Aterido said. 'Similar gaps exist across many specialties.' Improving care and training also requires stronger research efforts. However, according to Aterido, this responsibility often falls on LGBTQ+ healthcare professionals. 'Most research on LGBTQ+ health is conducted by professionals within the community or by researchers affiliated with sexual and gender diversity groups. Time and again, LGBTQ+ healthcare professionals are the ones identifying these gaps in medical knowledge,' Aterido said.